Literature DB >> 2817860

Susceptibility of Haemophilus influenzae type b to ampicillin-sulbactam.

P H Azimi1, M G Dunphy.   

Abstract

Seventy-five strains of Haemophilus influenzae type b, including 45 beta-lactamase-positive strains, were tested by MIC and time kill studies for susceptibility to ampicillin-sulbactam at various ratios. beta-Lactamase-negative strains were inhibited by lower concentrations of ampicillin-sulbactam than beta-lactamase-positive organisms. beta-Lactamase-negative strains showed a decrease in CFU per milliliter by a factor of 10(4) after a 24-h incubation with ampicillin-sulbactam. beta-Lactamase-positive isolates showed an initial decrease by a factor of up to 10(2) CFU per milliliter, but by the end of incubation these isolates grew to approximately the same cell density as the antibiotic-free control regardless of ampicillin-sulbactam ratios. Caution should be exercised in the use of this combination in treatment of meningitis, in which a high bacterial density is commonly encountered.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2817860      PMCID: PMC172715          DOI: 10.1128/AAC.33.9.1620

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  11 in total

1.  Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis.

Authors:  W E Feldman
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

2.  Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children.

Authors:  M H Lebel; G H McCracken
Journal:  Pediatrics       Date:  1989-02       Impact factor: 7.124

3.  Optimal dilution susceptibility testing conditions, recommendations for MIC interpretation, and quality control guidelines for the ampicillin-sulbactam combination.

Authors:  R N Jones; A L Barry
Journal:  J Clin Microbiol       Date:  1987-10       Impact factor: 5.948

4.  Sulbactam/ampicillin vs. chloramphenicol/ampicillin for the treatment of meningitis in infants and children.

Authors:  W J Rodríguez; W N Khan; J Puig; J Feris; S Harmon; B G Gold; S Ahmad
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

5.  Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children.

Authors:  W J Barson; M A Miller; M T Brady; D A Powell
Journal:  Pediatr Infect Dis       Date:  1985 Jul-Aug

6.  Treatment of bacterial meningitis with ceftizoxime.

Authors:  G D Overturf; D C Cable; D N Forthal; C Shikuma
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

7.  Ceftazidime vs. standard therapy for pediatric meningitis: therapeutic, pharmacologic and epidemiologic observations.

Authors:  W J Rodriguez; J R Puig; W N Khan; J Feris; B G Gold; C Sturla
Journal:  Pediatr Infect Dis       Date:  1986 Jul-Aug

Review 8.  Antibiotic resistance in Haemophilus influenzae: epidemiology, mechanisms, and therapeutic possibilities.

Authors:  J D Williams; F Moosdeen
Journal:  Rev Infect Dis       Date:  1986 Nov-Dec

9.  Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis.

Authors:  J M Decazes; J D Ernst; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

10.  Intravenous cefotaxime in children with bacterial meningitis.

Authors:  B H Belohradsky; K Bruch; D Geiss; D Kafetzis; W Marget; G Peters
Journal:  Lancet       Date:  1980-01-12       Impact factor: 79.321

View more
  1 in total

Review 1.  Ampicillin/sulbactam: current status in severe bacterial infections.

Authors:  Petros I Rafailidis; Eleni N Ioannidou; Matthew E Falagas
Journal:  Drugs       Date:  2007       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.